PuSH - Publikationsserver des Helmholtz Zentrums München

Thiel, E.V.

Leukamiezell - analyse bei der Diagnose der all/aul: Klinische wertigkeit heute verfügbarer Methoden.

Leukemic cell analysis at diagnosis ALL/AUL: Clinical relevance of methods available today

Onkologie 9, 60-65 (1986)
PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
After morphology and cytochemistry, immunological leukemic cell diagnosis became a generally available method by the development of monoclonal antibodies. Besides an otherwise not possible classification of nonmyeloid leukemias according to T- or B-differentiation status, precision and standardization of leukemia diagnosis is accomplished by immunodiagnostic means in an experimental way, an important point for therapy studies. In children, the common ALL - a precursor B-ALL type - was prognostically more favorable than the T-ALL which differs also in clinical appearance and in prognostic factors. In adults, however, T-ALL had a better prognosis than common ALL in a prospective trial. The heterogenous Null-ALL which makes up 23% of ALL in adults and 5% in children, was the prognostically most unfavorable form besides the rare B-ALL (1-2%), the immunophenotype being an independent prognostic variable. Immunodiagnostic means are therefore of utmost clinical importance compared to other methods such as cytogenetic and electron microscopy that are not performable in a corresponding extent.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
ISSN (print) / ISBN 0378-584X
e-ISSN 1423-0240
Zeitschrift Onkologie
Quellenangaben Band: 9, Heft: 2, Seiten: 60-65 Artikelnummer: , Supplement: ,
Verlag Karger
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed